Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Hudson

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|May 21, 1997
Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell linesM A Hudson, L M McReynolds
Human Pathology|March 1, 1992
Early detection of prostate cancerP T Scardino, R Weaver, M A Hudson
The Journal of Urology|October 1, 1989
Clinical use of prostate specific antigen in patients with prostate cancerM A Hudson, R R Bahnson, W J Catalona
The Journal of Urology|June 1, 1994
Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatmentJ F McCarthy, W J Catalona, M A Hudson
Scottish Medical Journal|July 1, 1984
Can erythema nodosum and reactive arthritis be a sequel to Shigella flexneri gastroenteritis?W D Neithercut, M A Hudson, C C Smith
Urology|February 1, 1991
Bilateral renal cell carcinoma with metastasis to thyroidM A Hudson, L R Kavoussi, W J Catalona
The Journal of Urology|October 23, 1997
Urinary interleukin-8/creatinine level as a predictor of response to intravesical bacillus Calmette-Guerin therapy in bladder tumor patientsR Rabinowitz, D S Smith, D D Tiemann, et al.
The Journal of Urology|December 1, 1990
Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumorsM A Hudson, J J Yuan, W J Catalona, et al.
Dimensions of Critical Care Nursing : DCCN|November 1, 1986
Nutritional assessment of protein statusM E Blazey, E M Brewer, M A Hudson, et al.
The Journal of Urology|August 1, 1994
Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapyR B Nadler, W J Catalona, M A Hudson, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|May 21, 1997
Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell linesM A Hudson, L M McReynolds
Human Pathology|March 1, 1992
Early detection of prostate cancerP T Scardino, R Weaver, M A Hudson
The Journal of Urology|October 1, 1989
Clinical use of prostate specific antigen in patients with prostate cancerM A Hudson, R R Bahnson, W J Catalona
The Journal of Urology|June 1, 1994
Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatmentJ F McCarthy, W J Catalona, M A Hudson
Scottish Medical Journal|July 1, 1984
Can erythema nodosum and reactive arthritis be a sequel to Shigella flexneri gastroenteritis?W D Neithercut, M A Hudson, C C Smith
Urology|February 1, 1991
Bilateral renal cell carcinoma with metastasis to thyroidM A Hudson, L R Kavoussi, W J Catalona
The Journal of Urology|October 23, 1997
Urinary interleukin-8/creatinine level as a predictor of response to intravesical bacillus Calmette-Guerin therapy in bladder tumor patientsR Rabinowitz, D S Smith, D D Tiemann, et al.
The Journal of Urology|December 1, 1990
Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumorsM A Hudson, J J Yuan, W J Catalona, et al.
Dimensions of Critical Care Nursing : DCCN|November 1, 1986
Nutritional assessment of protein statusM E Blazey, E M Brewer, M A Hudson, et al.
The Journal of Urology|August 1, 1994
Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapyR B Nadler, W J Catalona, M A Hudson, et al.
Pageof 4